[1] Wang AY, Ninomiya T, Al-Kahwa A, et al. Effect of hemodiafiltration or hemofiltration compared with hemodialysis on mortality and cardiovascular disease in chronic kidney failure:a systematic review and meta-analysis of randomized trials[J]. Am J Kidney Dis, 2014,63(6):968-978.
[2] Nistor I, Palmer SC, Craig JC, et al. Haemodiafiltration, haemofiltration and haemodialysis for end-stage kidney disease[J]. Cochrane Database Syst Rev, 2015, 20(5):CD006258.
[3] Suzuki M, Satoh N, Nakamura M, et al. Bacteremia in hemodialysis patients[J]. World J Nephrol, 2016, 5(6):489.
[4] Jalalzadeh M, Saber HR, Vafaeimanesh J, et al. Association of Helicobacter pylori infection and serum albumin in patients on hemodialysis[J]. Iran J Kidney Dis, 2010, 4(4):312-316.
[5] Gu M, Xiao S, Pan X, et al. Helicobacter pylori infection in dialysis patients:A Meta-analysis[J]. Gastroenterol Res Pract, 2013, 2013:785892.
[6] Moriyama T, Matsumoto T, Hirakawa K, et al. Helicobacter pylori status and esophagogastroduodenal mucosal lesions in patients with end-stage renal failure on maintenance hemodialysis[J]. J Gastroenterology, 2010, 45(5):515-522.
[7] Shirazian S, Radhakrishnan J. Gastrointestinal disorders and renal failure:exploring the connection[J]. Nat Rev Nephrol, 2010, 6(8):480-492.
[8] Khedmat H, Ahmadzad-Asl M, Amini M, et al. Gastroduodenal lesions and Helicobacter pylori infection in uremic patients and renal transplant recipients[J]. Transplant Proc, 2007, 39(4):1003-1007.
[9] Sugano K, Tack J, Kuipers EJ, et al. Kyoto global consensus report on Helicobacter pylori gastritis[J]. Gut, 2015,64(9):1353-1367.
[10] Mohamad RT, Saberi Far M,Soleimani A, et al. Evaluation of noninvasive tests for diagnosis of Helicobacter pylori infection in hemodialysis patients[J]. J Nephropathol, 2013, 2(4):249-253.
[11] Lopez T, Questada M, Almirall J, et al. Usefulness of noninvasive test for diagnosis of in patients undergoing dialysis for chronic renal failure[J]. Helicobacter, 2004, 9(6):674-680.
[12] Wang YL, Sheu BS, Huang JJ, et al. Noninvasive stool antigen assay can effectively screen Helicobacter pylori infection and assess success or eradication therapy in hemodilysis patients[J]. Am J Kidney Dis, 2001, 38(1):98-103.
[13] Nakajima F, Sakaguchi M, Amemoto K, et al. Helicobacter pylori in patients receiving long-term dialysis[J]. Am J Nephrol, 2002, 22(5/6):468-472.
[14] Tsukada K, Miyazaki T, Katoh H, et al. Seven-day triple therapy with omeprazole, amoxicillin and clarithromycin for Helicobacter pylori infection in haemodialysis patients[J]. Scand J Gastroenterol, 2002, 37(11):1265-1268.
[15] Gioe FP, Cudia B, Romano G, et al. Role and clinical importance of Helicobacter pylori infection in hemodialysis patients[J]. G Chir, 2008, 29(3):81-84.
[16] Sugimoto M, Sakai K, Kita M, et al. Prevalence of Helicobacter pylori infection in long-term hemodialysis patients[J]. Kidney Int, 2009, 75(1):96-103.
[17] Sugimoto M, Yamaoka Y, Oita Y, et al. Review of Helicobacter pylori infection and chronic renal failure[J]. Ther Apher Dial, 2011, 15(1):1-9.
[18] Hwang IR, Kodama T, Kikuchi S, et al. Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1beta production in Helicobacter pylori infection[J]. Gastroenterology, 2002, 123:1793-1803.
[19] Hagymási K, Tulassay Z. Helicobacter pylori infection:New pathogenetic and clinical aspects[J]. World J Gastroenterol, 2014, 20(21):6386-6399.
[20] Hsu CH, Hu HY, Huang N, et al. Early eradication has a lower risk of peptic ulcer bleeding in Helicobacter pylori-infected chronic kidney disease patients[J]. Eur J Intern Med, 2016, 33:112-117.
[21] Aydemir S, Boyacioglu S, Gur G, et al. Helicobacter pylori infection in hemodialysis patients:susceptibility to amoxicillin and clarithromycin[J]. World J Gastroenterol, 2005, 11(6):842-845.
[22] Mak SK, Loo CK, Wong PN, et al. A retrospective study on efficacy of proton-pump inhibitor based triple therapy for eradication of Helicobacter pylori in patients with chronic renal failure[J]. Singapore Med J, 2003, 44(2):74-78.
[23] Sheu BS, Huang JJ, Yang HB, et al. The selection of triple therapy for Helicobacter pylori eradication in chronic renal insufficiency[J]. Aliment Pharmacol Ther, 2003, 17(10):1283-1290.
[24] Itatsu T, Miwa H, Nagahara A, et al. Eradication of Helicobacter pylori in hemodialysis patients[J]. Ren Fail, 2007, 29(1):97-102.
[25] Makhlough A, Fakheri H, Farkhani AR, et al. A comparison between standard triple therapy and sequential therapy on eradication of Helicobacter pylori in uremic patients:A randomized clinical trial[J]. Adv Biomed Res, 2014, 6:248.
[26] Makhlough A, Fakheri H, Hojati S, et al. A comparison between hybrid therapy and standard triple therapy for Helicobacter pylori eradication in patients with uremia:A randomized clinical trial[J]. Middle East J Dig Dis, 2016, 8(1):39-43.
[27] 沈晓慧,陶竹,王孟春.幽门螺杆菌感染的个体化治疗[J].中国实用内科杂志,2015,35(12):1041-1043.